1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Epiomic Epidemiology Series: Frontotemporal Lobe Dementia Forecast in 9 Major Markets 2015-2025

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Frontotemporal Lobe Dementia in 9 Major Markets

Frontotemporal lobe dementia (FTD) is a progressive degenerative disorder characterised by degeneration and atrophy of the frontal and anterior temporal lobes. It is the second most common neurodegenerative disorder resulting in dementia in the under 65's and a limited life expectancy. This report provides the current prevalent population for FTD across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a breakdown of the sub-group classifications of the disease, disease origin and tau protein mutations in the FTD patient population. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of FTD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for FTD include:

-Dementia and cognitive disorders
-Speech and semantic problems
-Limb/muscle weakness and rigidity
-Behavioural disorders
-Appetite changes

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global FTD’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of FTD and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on FTD’s prevalent population.
-Examination of the prevalence for different causative protein mutations in FTD.
-Identify sub-populations within FTD which require treatment.
-Gain an understanding of the specific markets that have the largest number of FTD patients.

Table Of Contents

Epiomic Epidemiology Series: Frontotemporal Lobe Dementia Forecast in 9 Major Markets 2015-2025
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis and Clinical Course
-Key Co-morbid Conditions /Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Frontotemporal Lobe Dementia
-Main Features of Frontotemporal Lobe Dementia
o FTD Clinical Syndrome Classification
o Type of FTD by Protein Mutation
o Neurological Diseases Associated with FTD Patients
o Behavioural Disorders in FTD Patients
-Abbreviations used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Tables
-Prevalence of FTD, total (000s)
-Prevalence of FTD, males (000s)
-Prevalence of FTD, females (000s)
-Sub-group classification of FTD, total (000s)
-Origin of FTD in patients, total (000s)
-Tau mutation type in FTD patients, total (000s)
-Alzheimer's disease in FTD patients, total (000s)
-ALS in FTD patients, total (000s)
-Disinhibition in FTD patients, total (000s)
-Agitation in FTD patients, total (000s)
-Anxiety in FTD patients, total (000s)
-Apathy in FTD patients, total (000s)
-Abbreviations and acronyms used in the report
-USA Prevalence of FTD by 5-yr age cohort, males (000s)
-USA Prevalence of FTD by 5-yr age cohort, females (000s)
-France Prevalence of FTD by 5-yr age cohort, males (000s)
-France Prevalence of FTD by 5-yr age cohort, females (000s)
-Germany Prevalence of FTD by 5-yr age cohort, males (000s)
-Germany Prevalence of FTD by 5-yr age cohort, females (000s)
-Italy Prevalence of FTD by 5-yr age cohort, males (000s)
-Italy Prevalence of FTD by 5-yr age cohort, females (000s)
-Spain Prevalence of FTD by 5-yr age cohort, males (000s)
-Spain Prevalence of FTD by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of FTD by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of FTD by 5-yr age cohort, females (000s)
-Brazil Prevalence of FTD by 5-yr age cohort, males (000s)
-Brazil Prevalence of FTD by 5-yr age cohort, females (000s)
-Japan Prevalence of FTD by 5-yr age cohort, males (000s)
-Japan Prevalence of FTD by 5-yr age cohort, females (000s)
-India Prevalence of FTD by 5-yr age cohort, males (000s)
-India Prevalence of FTD by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Haemophagocytic lymphohistiocytosis (HLH) Forecast in 14 Major Markets 2016-2026

Epiomic Epidemiology Series: Haemophagocytic lymphohistiocytosis (HLH) Forecast in 14 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Haemophagocytic lymphohistiocytosis in 14 Major Markets Haemophagocytic lymphohistiocytosis (HLH) is an extremely rare haematological ...

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Urinary Incontinence  - Market Insights, Epidemiology and Market Forecast-2023

Urinary Incontinence  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Urinary Incontinence for the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.